A bispecific peptide-polymer conjugate bridging target-effector cells to enhance immunotherapy.
Sign Up to like & getrecommendations! Published in 2023 at "Advanced healthcare materials"
DOI: 10.1002/adhm.202202977
Abstract: Peptide-based immune checkpoint inhibitors exhibited remarkable therapeutic benefits although their application was hindered by quick blood clearance and low affinity with receptors. The modification of the peptides into artificial antibodies was an ideal platform to… read more here.
Keywords: polymer conjugate; immunotherapy; bispecific peptide; effector cells ... See more keywords